NOT-NS-21-045: Notice of Change to Key Dates for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"

Notice of Change to Key Dates for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"

Notice Number:

NOT-NS-21-045

Key Dates

Release Date:

March 1, 2021

Related Announcements

PAR-21-059 - Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This notice informs applicants of a change to the Key Dates for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". Due to an error with the open date of this Funding Opportunity Announcement (FOA), the first receipt date for this FOA has been moved back to March 15, 2021.

The following section of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)" has been modified, as indicated below.

Currently Reads:

Part 1. Overview

Key Dates

Open Date (Earliest Submission Date)

January 22, 2022

Application Due Date(s)

February 22, 2021, June 22, 2021, February 22, 2022, June 22, 2022, February 22, 2023, and June 22, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Modified to Read (changes shown in bold italics)

Part 1. Overview

Key Dates:

Open Date (Earliest Submission Date)

January 22, 2021

Application Due Date(s)

March 15, 2021, June 22, 2021, February 22, 2022, June 22, 2022, February 22, 2023, and June 22, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Carol Taylor-Burds, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]